BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BNTX BioNTech SE

盘后交易 10-02 17:22:19 EDT

112.75

+4.11

+3.78%

盘后112.32

-0.43-0.38%

16:39 EDT

最高113.04	最低108.07	成交量111.65万
今开109.25	昨收108.64	日振幅4.57%
总市值270.34亿	流通市值97.10亿	总股本2.40亿
成交额1.25亿	换手率1.30%	流通股本8,612万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BNTX","market":"US","secType":"STK","nameCN":"BioNTech SE","latestPrice":112.75,"timestamp":1696276800000,"preClose":108.64,"halted":0,"volume":1116478,"hourTrading":{"tag":"盘后","latestPrice":112.32,"preClose":112.75,"latestTime":"16:39 EDT","volume":12524,"amount":1412064.84404,"timestamp":1696279171112},"delay":0,"floatShares":86120236,"shares":239771156,"eps":19.730907,"marketStatus":"盘后交易","marketStatusCode":4,"change":4.11,"latestTime":"10-02 17:22:19 EDT","open":109.25,"high":113.04,"low":108.07,"amount":124505350.44926,"amplitude":0.045747,"askPrice":113.04,"askSize":1,"bidPrice":112.04,"bidSize":25,"shortable":3,"etf":0,"ttmEps":19.730907,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1696291200000},"adr":0,"listingDate":1570680000000,"adjPreClose":108.64,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":109.08,"preClose":108.64,"latestTime":"09:29 EDT","volume":5197,"amount":568439.1810100001,"timestamp":1696253380123},"postHourTrading":{"tag":"盘后","latestPrice":112.32,"preClose":112.75,"latestTime":"16:39 EDT","volume":12524,"amount":1412064.84404,"timestamp":1696279171112},"volumeRatio":1.862695},"requestUrl":"/m/hq/s/BNTX/wiki","defaultTab":"wiki","newsList":[{"id":"2372720838","title":"两位科学家获2023年诺贝尔生理学或医学奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2372720838","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2372720838?lang=zh_cn&edition=full","pubTime":"2023-10-02 22:44","pubTimestamp":1696257866,"startTime":"0","endTime":"0","summary":"北京时间10月2日，瑞典卡罗琳医学院宣布，将诺贝尔生理学或医学奖授予Katalin Karikó、Drew Weissman，以表彰他们在核苷碱基修饰方面的发现，这些发现使得针对COVID-19的有效mRNA疫苗得以开发。他们将平均分享1100万瑞典克朗的奖金。\n\n\r\n            责任编辑：史文瑞","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2023/10/cms_20231002224426158.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2023/10/cms_20231002224426158.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/10/02224437931676.shtml","is_publish_highlight":false},{"id":"2371654250","title":"Biontech Se盘中异动 早盘股价大涨5.21%报107.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2371654250","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2371654250?lang=zh_cn&edition=full","pubTime":"2023-09-29 22:56","pubTimestamp":1695999367,"startTime":"0","endTime":"0","summary":"北京时间2023年09月29日22时56分，Biontech Se股票出现波动，股价大幅上涨5.21%。截至发稿，该股报107.35美元/股，成交量31.0582万股，换手率0.13%，振幅4.61%。Biontech Se股票所在的生物技术行业中，整体跌幅为0.06%。Biontech Se公司简介：BioNTech SE是一家总部位于德国的生物技术公司，专注于开发个体化免疫疗法等癌症治疗药物以及COVID-19等传染病疫苗。Comirnaty 公司其第一个商业化产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309292256078069d8dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309292256078069d8dc&s=b","is_publish_highlight":false},{"id":"1181152303","title":"友宝在线过聆讯，截至6月底公司拥有61888个自动售货机点位","url":"https://stock-news.laohu8.com/highlight/detail?id=1181152303","media":"智通财经APP","top":-1,"share":"https://www.laohu8.com/m/news/1181152303?lang=zh_cn&edition=full","pubTime":"2023-09-28 17:35","pubTimestamp":1695893725,"startTime":"0","endTime":"0","summary":"招股书显示，友宝在线是中国大陆自动售货机经营商，按2022 年商品总额计算，占市场份额7.6%。截至2023年6月30日，公司的网络拥有61888个自动售货机友宝点位，遍布中国大陆157个城市及28个省级行政区，其中有87.3%集中于一线、新一线及二线城市。公司的收益由截至2022年6月30日止六个月的11.43亿元增加至截至2023年6月30日止六个月的12.53亿元，主要由于随着COVID-19 政策放宽及客流量及业务活动整体恢复，无人零售业务及商品批发业务的收益增加。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true},{"id":"2370976727","title":"Atossa Therapeutics Inc盘中异动 早盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2370976727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2370976727?lang=zh_cn&edition=full","pubTime":"2023-09-27 21:33","pubTimestamp":1695821630,"startTime":"0","endTime":"0","summary":"北京时间2023年09月27日21时33分，Atossa Therapeutics Inc股票出现异动，股价急速上涨5.53%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Scisparc Ltd、Galecto Inc、Biohaven Ltd涨幅较大，Scisparc Ltd、Avalo Therapeutics Inc、Transcode Therapeutics Inc较为活跃，换手率分别为266.33%、152.87%、29.76%，振幅较大的相关个股有Scisparc Ltd、Lipella Pharmaceuticals Inc、Vaccitech Plc，振幅分别为31.07%、14.50%、14.18%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230927213350838f37ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230927213350838f37ce&s=b","is_publish_highlight":false},{"id":"2370106209","title":"Atossa Therapeutics Inc盘中异动 急速拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2370106209","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2370106209?lang=zh_cn&edition=full","pubTime":"2023-09-27 01:21","pubTimestamp":1695748898,"startTime":"0","endTime":"0","summary":"北京时间2023年09月27日01时21分，Atossa Therapeutics Inc股票出现异动，股价大幅拉升5.49%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Soleno Therapeutics Inc、Immunovant Inc、Intercept Pharmaceuticals Inc涨幅较大，Avalo Therapeutics Inc、Transcode Therapeutics Inc、Soleno Therapeutics Inc较为活跃，换手率分别为1627.52%、472.41%、321.23%，振幅较大的相关个股有Soleno Therapeutics Inc、Biocardia Inc C/Wts 06/08/2024、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为194.57%、65.44%、61.03%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092701213982f6cdfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092701213982f6cdfa&s=b","is_publish_highlight":false},{"id":"2370260513","title":"Atossa Therapeutics Inc盘中异动 早盘股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2370260513","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2370260513?lang=zh_cn&edition=full","pubTime":"2023-09-25 21:33","pubTimestamp":1695648814,"startTime":"0","endTime":"0","summary":"北京时间2023年09月25日21时33分，Atossa Therapeutics Inc股票出现异动，股价快速下跌6.40%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Clene Inc C/Wts 30/12/2025 、Biophytis、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Avalo Therapeutics Inc、Biophytis、Paxmedica Inc较为活跃，换手率分别为259.80%、135.34%、15.59%，振幅较大的相关个股有Monopar Therapeutics Inc、Applied Molecular Transport Inc、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为16.61%、14.30%、12.82%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092521333482f674fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092521333482f674fd&s=b","is_publish_highlight":false},{"id":"2369549014","title":"Atossa Therapeutics Inc盘中异动 早盘股价大涨5.10%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2369549014","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2369549014?lang=zh_cn&edition=full","pubTime":"2023-09-22 22:59","pubTimestamp":1695394751,"startTime":"0","endTime":"0","summary":"北京时间2023年09月22日22时59分，Atossa Therapeutics Inc股票出现异动，股价急速拉升5.10%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Avalo Therapeutics Inc、Synaptogenix Inc、Shattuck Labs Inc涨幅较大，Avalo Therapeutics Inc、Synaptogenix Inc、Aditxt Inc较为活跃，换手率分别为1114.21%、91.50%、52.02%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Eqrx Inc C/Wts 17/12/2026 、Synaptogenix Inc，振幅分别为167.89%、46.13%、40.69%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092222591182f5eac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023092222591182f5eac2&s=b","is_publish_highlight":false},{"id":"2368191859","title":"Atossa Therapeutics Inc盘中异动 股价大跌5.12%报0.750美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2368191859","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2368191859?lang=zh_cn&edition=full","pubTime":"2023-09-18 21:51","pubTimestamp":1695045072,"startTime":"0","endTime":"0","summary":"北京时间2023年09月18日21时51分，Atossa Therapeutics Inc股票出现波动，股价大幅下挫5.12%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.67%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。该公司正在开发的治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230918215112838cbccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230918215112838cbccd&s=b","is_publish_highlight":false},{"id":"2368699066","title":"BioNTech(BNTX.US)与CEPI合作开发猴痘疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2368699066","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2368699066?lang=zh_cn&edition=full","pubTime":"2023-09-18 21:35","pubTimestamp":1695044134,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德国生物技术公司BioNTech(BNTX.US)将与流行病预防创新联盟(CEPI)合作开发基于mRNA的猴痘疫苗。BioNTech将开始BNT166治疗猴痘的1/2期临床试验。CEPI承诺提供9000万美元资金。这一伙伴关系还将支持CEPI的“100天使命”，其目标是加快针对未来可能出现的大流行病毒的疫苗开发，以便在发现病原体后的100天内为授权和大规模生产做好准备。截至发稿，BioNTech跌0.76%，报112.20美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/996340.html","is_publish_highlight":false},{"id":"2367168645","title":"民调：半数美国人对接种最新COVID-19疫苗感兴趣","url":"https://stock-news.laohu8.com/highlight/detail?id=2367168645","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2367168645?lang=zh_cn&edition=full","pubTime":"2023-09-16 00:12","pubTimestamp":1694794334,"startTime":"0","endTime":"0","summary":"路透社与益普索集团的一项最新民意调查显示，约半数美国人有兴趣接种更新的COVID-19疫苗。近30%的受访者对接种疫苗非常感兴趣，另有24%的受访者表示有点感兴趣。近17%的人不太感兴趣，30%的人完全不感兴趣。美国公共卫生官员本周早些时候建议接种辉瑞/BioNTech和莫德纳公司生产的针对最近流行的冠状病毒Omicron变种的COVID-19更新疫苗。\n\n\r\n            责任编辑：史文瑞","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/09/16001237868125.shtml","is_publish_highlight":false},{"id":"2367376255","title":"Atossa Therapeutics Inc盘中异动 大幅下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2367376255","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2367376255?lang=zh_cn&edition=full","pubTime":"2023-09-13 02:30","pubTimestamp":1694543431,"startTime":"0","endTime":"0","summary":"北京时间2023年09月13日02时30分，Atossa Therapeutics Inc股票出现波动，股价快速下挫5.08%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Axcella Health Inc、Avalo Therapeutics Inc、Clene Inc C/Wts 30/12/2025 涨幅较大，Avalo Therapeutics Inc、Axcella Health Inc、Novabay Pharmaceuticals Inc较为活跃，换手率分别为1175.82%、131.38%、53.10%，振幅较大的相关个股有Axcella Health Inc、Avalo Therapeutics Inc、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为115.81%、77.03%、43.59%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091302303182f3259d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091302303182f3259d&s=b","is_publish_highlight":false},{"id":"2365280825","title":"Atossa Therapeutics Inc股价上涨10.28% 市值涨837.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2365280825","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2365280825?lang=zh_cn&edition=full","pubTime":"2023-09-08 22:33","pubTimestamp":1694183618,"startTime":"0","endTime":"0","summary":"北京时间2023年09月08日22时33分，Atossa Therapeutics Inc股票出现波动，股价快速上涨10.28%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.47%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。消息层面，截至22时33分，Atossa Therapeutics Inc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309082233398069a1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309082233398069a1f6&s=b","is_publish_highlight":false},{"id":"2360455063","title":"Biontech Se盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2360455063","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2360455063?lang=zh_cn&edition=full","pubTime":"2023-08-18 03:51","pubTimestamp":1692301878,"startTime":"0","endTime":"0","summary":"北京时间2023年08月18日03时51分，Biontech Se股票出现波动，股价急速上涨5.01%。截至发稿，该股报113.37美元/股，成交量80.5158万股，换手率0.34%，振幅5.10%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.04%。Biontech Se公司简介：BioNTech SE 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法以及传染病疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023081803511883837250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023081803511883837250&s=b","is_publish_highlight":false},{"id":"2359382871","title":"Atossa Therapeutics Inc盘中异动 早盘快速上涨6.13%报0.935美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2359382871","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2359382871?lang=zh_cn&edition=full","pubTime":"2023-08-16 22:42","pubTimestamp":1692196939,"startTime":"0","endTime":"0","summary":"北京时间2023年08月16日22时42分，Atossa Therapeutics Inc股票出现异动，股价快速上涨6.13%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.24%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。该公司正在开发的治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230816224219806858d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230816224219806858d8&s=b","is_publish_highlight":false},{"id":"2359846947","title":"Atossa Therapeutics Inc盘中异动 股价大跌6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2359846947","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2359846947?lang=zh_cn&edition=full","pubTime":"2023-08-15 23:15","pubTimestamp":1692112533,"startTime":"0","endTime":"0","summary":"北京时间2023年08月15日23时15分，Atossa Therapeutics Inc股票出现波动，股价急速下挫6.15%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.36%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。该公司正在开发的治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202308152315338382b070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202308152315338382b070&s=b","is_publish_highlight":false},{"id":"2359792830","title":"Biontech Se2023财年第二财季实现净利润-2.07亿美元，同比减少111.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2359792830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2359792830?lang=zh_cn&edition=full","pubTime":"2023-08-14 00:04","pubTimestamp":1691942667,"startTime":"0","endTime":"0","summary":"6月30日，Biontech Se公布财报，公告显示公司2023财年第二财季净利润为-2.07亿美元，同比减少111.64%；其中营业收入为1.83亿美元，同比减少94.62%，每股基本收益为-0.86美元。从资产负债表来看，Biontech Se总负债25.30亿美元，其中短期债务42.11百万美元，资产负债比为9.59，流动比率为10.57。机构评级：截至2023年6月30日，当前有16家机构对Biontech Se目标价做出预测，其中目标均价为162.06美元，其中最低目标价为100.53美元，最高目标价为260.01美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023081400043384742cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023081400043384742cf7&s=b","is_publish_highlight":false},{"id":"2358441759","title":"Biontech Se盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2358441759","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2358441759?lang=zh_cn&edition=full","pubTime":"2023-08-09 22:42","pubTimestamp":1691592128,"startTime":"0","endTime":"0","summary":"北京时间2023年08月09日22时42分，Biontech Se股票出现异动，股价急速上涨5.01%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.01%。Biontech Se公司简介：BioNTech SE 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法以及传染病疫苗。消息层面，截至22时42分，《BioNTech跌超7% 二季度营收同比大降 远逊预期值》资讯为影响Biontech Se的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080922420884741dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080922420884741dc2&s=b","is_publish_highlight":false},{"id":"2358225441","title":"Atossa Therapeutics Inc盘中异动 股价大涨5.76%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2358225441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2358225441?lang=zh_cn&edition=full","pubTime":"2023-08-08 23:50","pubTimestamp":1691509837,"startTime":"0","endTime":"0","summary":"北京时间2023年08月08日23时50分，Atossa Therapeutics Inc股票出现异动，股价急速拉升5.76%。截至发稿，该股报1.10美元/股，成交量19.5264万股，换手率0.15%，振幅2.62%。Atossa Therapeutics Inc股票所在的生物技术行业中，整体涨幅为6.01%。Atossa Therapeutics Inc公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。该公司正在开发的治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080823503783806823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080823503783806823&s=b","is_publish_highlight":false},{"id":"2358222591","title":"Biontech Se涨1.53% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2358222591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2358222591?lang=zh_cn&edition=full","pubTime":"2023-08-08 21:50","pubTimestamp":1691502646,"startTime":"0","endTime":"0","summary":"北京时间2023年08月08日21时50分，Biontech Se股票出现异动，股价大幅拉升1.53%。Biontech Se股票所在的生物技术行业中，整体涨幅为5.38%。Biontech Se公司简介：BioNTech SE 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法以及传染病疫苗。消息层面，截至21时50分，《BioNTech跌超7% 二季度营收同比大降 远逊预期值》资讯为影响Biontech Se的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080821504682e84b19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023080821504682e84b19&s=b","is_publish_highlight":false},{"id":"2357253207","title":"美股异动 | BioNTech(BNTX.US)Q2营收同比降95% 股价跌近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2357253207","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2357253207?lang=zh_cn&edition=full","pubTime":"2023-08-07 23:20","pubTimestamp":1691421657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，BioNTech(BNTX.US)股价走低，截至发稿，该股跌近10%，报95.99美元。该公司Q2营收为1.68亿欧元，同比下降94.8%，市场预期为6.28亿欧元。BioNTech与辉瑞(PFE.US)合作开发的新冠疫苗需求大幅下降，BioNTech第二季度销售额大幅下降，尽管成本基础下降，但仍公布了自2020年以来的首次季度净亏损。Q2净亏损为1.904亿欧元，上年同期为16.72亿欧元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/971971.html","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":-0.1314},{"period":"3month","weight":0.0066},{"period":"6month","weight":-0.1279},{"period":"1year","weight":-0.1868},{"period":"ytd","weight":-0.2768}],"websiteUrl":"http://www.biontech.de","compareEarnings":[{"period":"1week","weight":-0.0068},{"period":"1month","weight":-0.0522},{"period":"3month","weight":-0.0356},{"period":"6month","weight":0.0442},{"period":"1year","weight":0.1783},{"period":"ytd","weight":0.1178}],"name":"BioNTech SE","description":"BioNTech SE成立于2008年6月2日。该公司结合了数十年的免疫学，尖端治疗平台以及各种患者分析和生物信息学工具的开创性研究，开发针对癌症和其他疾病的个体化免疫疗法。该公司利用强大的新治疗机制，利用各种生物学靶点，利用每位患者免疫系统的力量，解决每位患者潜在疾病的独特分子特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.020296},{"month":2,"riseRate":0.25,"avgChangeRate":-0.020691},{"month":3,"riseRate":0.75,"avgChangeRate":0.188527},{"month":4,"riseRate":0.25,"avgChangeRate":0.067024},{"month":5,"riseRate":0.75,"avgChangeRate":0.0559},{"month":6,"riseRate":0.75,"avgChangeRate":0.096187},{"month":7,"riseRate":1,"avgChangeRate":0.203321},{"month":8,"riseRate":0.5,"avgChangeRate":-0.066227},{"month":9,"riseRate":0.25,"avgChangeRate":-0.052386},{"month":10,"riseRate":1,"avgChangeRate":0.091493},{"month":11,"riseRate":1,"avgChangeRate":0.309414},{"month":12,"riseRate":0.25,"avgChangeRate":-0.042527}],"exchange":"NASDAQ","nameEN":"BioNTech SE","compareStock":{"symbol":"SPY","name":"标普500ETF"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.17.2","shortVersion":"4.17.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioNTech SE,BNTX,BioNTech SE股票,BioNTech SE股票老虎,BioNTech SE股票老虎国际,BioNTech SE行情,BioNTech SE股票行情,BioNTech SE股价,BioNTech SE股市,BioNTech SE股票价格,BioNTech SE股票交易,BioNTech SE股票购买,BioNTech SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}